(Circulation. 2001;103:2159.)
© 2001 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Division of Cardiology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, Calif.
Correspondence to Charles D. Swerdlow, MD, 8635 W Third Street, Ste 1190W, Los Angeles, CA 90048. E-mail swerdlow{at}ucla.edu
BackgroundThe upper limit of vulnerability (ULV) is the weakest shock at which ventricular fibrillation (VF) is not induced by a T-wave shock. This study tested the hypothesis that a vulnerability safety margin based on the ULV can be used as an implantable cardioverter-defibrillator implantation criterion.
Methods and
ResultsImplantable
cardioverter-defibrillators were implanted in 80 patients if T-wave
shocks did not induce VF and the baseline-rhythm R wave was
7 mV. The
T-wave shock was 10 J in the first 45 patients (group A) and 15 J in
the last 35 patients (group B). After inductionless implantations, the
first VF shock was programmed to the T-wave shock plus 5 J. If T-wave
shocks induced VF, the ULV was measured and the first shock was
programmed to the ULV+5 J. Inductionless implantations were
performed in 58 patients (72%), 28 in group A (62%) and 30 in group B
(86%; P=0.04). If T-wave
scanning had been done at 15 J in group A patients, inductionless
implantations could have been performed in 84% of them. At 3 months,
VF was induced twice during
electrophysiological study in 75 patients
(94%). All VFs were detected in
4.7 s and were terminated by the
first shock. During follow-up, 197 of 198 appropriate first shocks for
rapid ventricular tachycardia or VF (99%) were
successful in patients who had inductionless implantations (95%
confidence intervals, 97% to 100%).
ConclusionInductionless implantations can be performed in >80% of implantable cardioverter-defibrillator recipients using a vulnerability safety margin based on a T-wave scan at 15 J.
Key Words: defibrillation defibrillators, implantable shock
This article has been cited by other articles:
![]() |
B. Lemke, T. Lawo, M. Zarse, A. Lubinski, U. Kreutzer, J. Mueller, A. Schuchert, S. Mitzenheim, D. Danilovic, T. Deneke, et al. Patient-tailored implantable cardioverter defibrillator testing using the upper limit of vulnerability: the TULIP protocol Europace, August 1, 2008; 10(8): 907 - 913. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Day, R. N. Doshi, P. Belott, U. Birgersdotter-Green, M. Behboodikhah, P. Ott, K. A. Glatter, S. Tobias, H. Frumin, B. K. Lee, et al. Inductionless or Limited Shock Testing Is Possible in Most Patients With Implantable Cardioverter- Defibrillators/Cardiac Resynchronization Therapy Defibrillators: Results of the Multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations) Circulation, May 8, 2007; 115(18): 2382 - 2389. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Swerdlow Reappraisal of implant testing of implantable cardioverter defibrillators J. Am. Coll. Cardiol., July 7, 2004; 44(1): 92 - 94. [Full Text] [PDF] |
||||
![]() |
C. Swerdlow, K. Shivkumar, and J. Zhang Determination of the Upper Limit of Vulnerability Using Implantable Cardioverter-Defibrillator Electrograms Circulation, June 24, 2003; 107(24): 3028 - 3033. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |